Who owns Corvus Pharmaceuticals?

Tip: Access positions for across all investors

Analyze quarterly positions in Corvus Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Corvus Pharmaceuticals stock

Who bought or sold Corvus Pharmaceuticals this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of
OrbiMed Advisors 6.9M $34M -14% Sep 2021
Tang Capital Management 3.7M $18M 100% Sep 2021
VR Adviser 3.4M $17M 100% Sep 2021
Adams Street Partners 3.3M $16M 0% Sep 2021
EcoR1 Capital 2.1M $10M -42% Sep 2021
BVF 1.4M $6.6M -63% Sep 2021
Vanguard Group 1.2M $5.8M 8% Sep 2021
Ikarian Capital 758k $3.7M 658% Sep 2021
Pura Vida Investments 734k $3.6M 100% Sep 2021
Millennium Management 691k $3.3M 426% Sep 2021
Renaissance Technologies 614k $3.0M -7% Sep 2021

Setup an alert

Want to be notified whenever an investor makes a significant change to their holdings of Corvus Pharmaceuticals?

Jane Street 601k $2.9M 100% Sep 2021
Point72 Asset Management 575k $2.8M 100% Sep 2021
Susquehanna International 553k $2.7M 380% Sep 2021
Citadel Advisors 550k $2.7M 669% Sep 2021
Artal Group 500k $2.4M 100% Sep 2021
Geode Capital Management 210k $1.0M 11% Sep 2021
Adage Capital Partners GP 200k $968k 100% Sep 2021
Telemetry Investments 196k $949k -26% Sep 2021
Dimensional Fund Advisors 180k $874k -55% Sep 2021
CHI Advisors 166k $803k -77% Sep 2021
Bridgeway Capital Management 159k $771k -24% Sep 2021
Two Sigma Investments 141k $680k -55% Sep 2021
Boothbay Fund Management 76k $366k 576% Sep 2021
State Street Corporation 66k $321k 124% Sep 2021
Belvedere Trading 63k $292k 100% Sep 2021
Wolverine Trading 63k $396k 100% Sep 2021
HAP Trading 60k $17k 100% Sep 2021
MYDA Advisors 60k $290k 100% Sep 2021
Northern Trust 59k $0 0% Sep 2021
Dean Capital Investments Management 51k $245k 100% Sep 2021
Affinity Asset Advisors 50k $242k 100% Sep 2021
Acadian Asset Management 41k $199k -19% Sep 2021
XR Securities 32k $73k 100% Sep 2021
Hrt Financial 31k $148k 100% Sep 2021
LMR Partners 30k $145k 100% Sep 2021
Cutler 23k $53k -92% Dec 2021
Two Sigma Securities 23k $110k 100% Sep 2021
Tower Research Capital 21k $101k 177% Sep 2021
Cubist Systematic Strategies 20k $97k 100% Sep 2021
Hikari Power 20k $48k 0% Dec 2021
Squarepoint Ops 20k $97k 100% Sep 2021
Virtu Financial 20k $95k 100% Sep 2021
Algert Coldiron Investors 15k $72k -24% Sep 2021
Charles Schwab Investment Management 11k $55k 100% Sep 2021
Envestnet Asset Management 11k $51k 0% Sep 2021
Mercer Global Advisors 11k $51k 0% Sep 2021
Zacks Investment Management 10k $48k 100% Sep 2021
Whittier Trust Co. of Nevada 4.2k $10k 0% Dec 2021
UBS Group 3.0k $15k 0% Sep 2021
Total Clarity Wealth Management 2.5k $12k 100% Sep 2021
Rockefeller Capital Management 1.8k $8.0k -30% Sep 2021
Tortoise Investment Management 1.7k $8.0k 100% Sep 2021
Advisor Group Holdings 1.1k $5.0k 0% Sep 2021
Meeder Asset Management 645.00 $3.0k 0% Sep 2021
TCI Wealth Advisors 300.00 $999.990000 100% Sep 2021
Simplex Trading 199.00 $0 0% Sep 2021
Wells Fargo & Company 182.00 $999.999000 10% Sep 2021
Steward Partners Investment Advisory 25.00 $0 100% Sep 2021
Parallel Advisors 20.00 $0 0% Sep 2021
Barclays 1.00 $0 -75% Sep 2021

Who sold out of Corvus Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Two Sigma Advisers Jun 2021 288k $770k
Laurion Capital Management Jun 2021 59k $158k
Stonepine Capital Management Jun 2021 47k $125k
Verition Fund Management Jun 2021 42k $112k
Natixis Jun 2021 28k $74k
Branch Banking & Trust Company Jun 2021 21k $56k
Windsor Creek Advisors Jun 2021 15k $39k
Lindbrook Capital Sep 2021 14k $68k
Group One Trading Jun 2021 7.1k $19k
PanAgora Asset Management Jun 2021 424.00 $1.0k